Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Ibrutinib | IC50 | 2.3 [1] | |
| N-(2-Chloro-6-methylphenyl)-2-[(2,6-dimethylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide | IC50 | 0.8 [1], 1.0 [2] | |
| N-[4-[4-Amino-7-[(E)-3-[(4-aminocyclohexyl)amino]prop-1-enyl]thieno[3,2-c]pyridin-3-yl]-2-methoxyphenyl]-1-methylindole-2-carboxamide | IC50 | 17900.0 [1], 21700.0 [2] | |
| 2-PropenaMide, N-[cis-4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]cyclohexyl]- | IC50 | 0.4 [1] | |
| Crizotinib | IC50 | 10000.0 [1] | |
MLA | "Quest Database™ Tyrosine-protein kinase FGR Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 15 Dec. 2025, https://www.aatbio.com/data-sets/tyrosine-protein-kinase-fgr-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 15). Quest Database™ Tyrosine-protein kinase FGR Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tyrosine-protein-kinase-fgr-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |